PURPOSE: This study assessed the effect of providing an enhanced medication plan (EMP) to patients during patient-physician conversation at hospital discharge and evaluated its immediate impact on patient knowledge on pharmacotherapy. METHODS: We observed patient-physician conversations at hospital discharge in three internal medicine wards of the University Hospital Heidelberg before and after the EMP was integrated into the discharge process, and documented how and to what extent physicians provided the patients with drug information. After the conversation, the patients' knowledge was evaluated by three standardized questions about their pharmacotherapy. RESULTS: We observed 90 conversations (50 before EMP-implementation, 40 after). In both phases, the conversation duration was 5.6-6 min (p = 0.56). However, the time spent on drug information increased significantly by 61.7% after EMP-implementation (+63 s, p = 0.02). Before implementation, physicians gave at least one drug administration recommendation for 75.1% of all drugs, compared to 84.6% after implementation (p = 0.02). The EMP provided information for almost all drugs (98.9%; p < 0.01) after implementation. Three times more patients answered all questions correctly after EMP-implementation (p < 0.01). CONCLUSION: The provision of an EMP improves information transfer and therefore increases the patients' knowledge of their individual drug treatment without prolonging the overall discharge process.
PURPOSE: This study assessed the effect of providing an enhanced medication plan (EMP) to patients during patient-physician conversation at hospital discharge and evaluated its immediate impact on patient knowledge on pharmacotherapy. METHODS: We observed patient-physician conversations at hospital discharge in three internal medicine wards of the University Hospital Heidelberg before and after the EMP was integrated into the discharge process, and documented how and to what extent physicians provided the patients with drug information. After the conversation, the patients' knowledge was evaluated by three standardized questions about their pharmacotherapy. RESULTS: We observed 90 conversations (50 before EMP-implementation, 40 after). In both phases, the conversation duration was 5.6-6 min (p = 0.56). However, the time spent on drug information increased significantly by 61.7% after EMP-implementation (+63 s, p = 0.02). Before implementation, physicians gave at least one drug administration recommendation for 75.1% of all drugs, compared to 84.6% after implementation (p = 0.02). The EMP provided information for almost all drugs (98.9%; p < 0.01) after implementation. Three times more patients answered all questions correctly after EMP-implementation (p < 0.01). CONCLUSION: The provision of an EMP improves information transfer and therefore increases the patients' knowledge of their individual drug treatment without prolonging the overall discharge process.
Authors: Alexander F J Send; Adel Al-Ayyash; Sabrina Schecher; Gottfried Rudofsky; Ulrike Klein; Matthias Schaier; Markus G Pruszydlo; Diana Witticke; Kristina Lohmann; Jens Kaltschmidt; Walter E Haefeli; Hanna M Seidling Journal: Br J Clin Pharmacol Date: 2013-09 Impact factor: 4.335
Authors: David Phillip Alldred; Claire Standage; Olivia Fletcher; Imogen Savage; James Carpenter; Nick Barber; David Kenneth Raynor Journal: BMJ Qual Saf Date: 2011-02-07 Impact factor: 7.035
Authors: Geert N Rootmensen; Anton R J van Keimpema; Henk M Jansen; Rob J de Haan Journal: J Aerosol Med Pulm Drug Deliv Date: 2010-10 Impact factor: 2.849
Authors: Julia Freigofas; Hanna Marita Seidling; Renate Quinzler; Ben Schöttker; Kai-Uwe Saum; Hermann Brenner; Walter Emil Haefeli Journal: Eur J Clin Pharmacol Date: 2015-06-24 Impact factor: 2.953
Authors: Ian Litchfield; David Fitzmaurice; Patricia Apenteng; Sian Harrison; Carl Heneghan; Alison Ward; Sheila Greenfield Journal: Br J Gen Pract Date: 2016-06-06 Impact factor: 5.386